User profiles for D. James Nokes
 | D. James NokesProfessor of Infectious Disease Epidemiology, KEMRI-Wellcome Trust, Kenya; University of … Verified email at kemri-wellcome.org Cited by 19844 |
[HTML][HTML] Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a …
…, DR Feikin, L Feng, A Gentile, A Gordon, D Goswami… - The Lancet, 2017 - thelancet.com
Background We have previously estimated that respiratory syncytial virus (RSV) was associated
with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) resulting in …
with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) resulting in …
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Background The global burden of disease attributable to respiratory syncytial virus (RSV)
remains unknown. We aimed to estimate the global incidence of and mortality from episodes of …
remains unknown. We aimed to estimate the global incidence of and mortality from episodes of …
A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
…, D Park, D Baker, D Doolabh, D Ssemwanga… - Science, 2021 - science.org
The progression of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic in Africa has so far been heterogeneous, and the full impact is not yet well understood…
pandemic in Africa has so far been heterogeneous, and the full impact is not yet well understood…
[HTML][HTML] Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years …
Background Respiratory syncytial virus (RSV) is the most common cause of acute lower
respiratory infection in young children. We previously estimated that in 2015, 33·1 million …
respiratory infection in young children. We previously estimated that in 2015, 33·1 million …
Viral etiology of severe pneumonia among Kenyan infants and children
Context Pneumonia is the leading cause of childhood death in sub-Saharan Africa.
Comparative estimates of the contribution of causative pathogens to the burden of disease are …
Comparative estimates of the contribution of causative pathogens to the burden of disease are …
[HTML][HTML] Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis
Background Influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus
are the most common viruses associated with acute lower respiratory infections in …
are the most common viruses associated with acute lower respiratory infections in …
[HTML][HTML] Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study
…, H Tall, M Ngama, DJ Nokes, DR Clark… - The Lancet Global …, 2020 - thelancet.com
Background Seasonal influenza virus is a common cause of acute lower respiratory
infection (ALRI) in young children. In 2008, we estimated that 20 million influenza-virus-associated …
infection (ALRI) in young children. In 2008, we estimated that 20 million influenza-virus-associated …
[HTML][HTML] Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series
…, A Gentile, F Lucion, DJ Nokes… - The Lancet Global …, 2017 - thelancet.com
Background Respiratory syncytial virus (RSV) infection is an important cause of pneumonia
mortality in young children. However, clinical data for fatal RSV infection are scarce. We …
mortality in young children. However, clinical data for fatal RSV infection are scarce. We …
[HTML][HTML] Strategic priorities for respiratory syncytial virus (RSV) vaccine development
… Dr. Anderson has done paid consultancies on RSV vaccines and therapeutics for MedImmune,
… Dr. James Nokes is on an advisory panel for GSK and has a proposal pending to GSK to …
… Dr. James Nokes is on an advisory panel for GSK and has a proposal pending to GSK to …
Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control
Hepatitis-B virus infection is globally ubiquitous, but its distribution is very heterogeneous,
with prevalence of serological markers in various nations ranging from less than 1% to more …
with prevalence of serological markers in various nations ranging from less than 1% to more …
